Role of interleukin 10 in specific immunotherapy

Journal of Clinical Investigation

Volumn 102, Issue 1, 1998, Pages 98-106

  Akdis, Cezmi A ^a   Blesken, Thorsten ^a   Akdis, Mübeccel ^a   Wüthrich, Brunello ^b   Blaser, Kurt ^a  

^a SWISS INSTITUTE OF ALLERGY AND ASTHMA RESEARCH SIAF   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Anergy; Bee venom allergy; Immunotherapy; Interleukin 10; Isotype regulation; T cell epitopes

Indexed keywords

INTERLEUKIN 10;

ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; CELL PROLIFERATION; CELL SPECIFICITY; CLONAL ANERGY; HUMAN; HUMAN CELL; IMMUNOTHERAPY; KILLER CELL; MEMORY CELL; MONOCYTE; PRIORITY JOURNAL; RECEPTOR AFFINITY; T LYMPHOCYTE ACTIVATION;

EID: 0032128421     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI2250     Document Type: Article

References (62)

1. Del Prete, G., E. Maggi, P. Paola, I. Ghretien, A. Tiri, D. Macchia, J. Banchereau, J.E. De Vries, and S. Romagnani. 1988. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. J. Immunol. 140:4193-4198.
2. Punnonen, J., G. Aversa, B.G. Cocks, A.N.J. McKenzie, S. Menon, G. Zurawski, R. De Waal Malefyt, and J.E. De Vries. 1993. Interleukin-13 induces interleukin-4 independent IgG4 and IgE synthesis und CD23 expression by human B cells. Proc. Natl. Acad. Sci. USA. 90:3730-3734.
3. Walker, C., J.C. Virchow, Jr., P.L.B. Bruijnzeel, and K. Blaser. 1991. T cell subsets and their soluble products regulate eosinophilia in allergic and non-allergic asthma. J. Immunol. 146:1829-1835.
4. Aalberse, R.C., R. van der Gaag, and J. van Leuwen. 1983. Serologic aspects of IgG4 antibodies. I. Prolonged immunization results in an IgG4-restricted response. J. Immunol. 130:722-726.
5. 2-specific human IgE and IgG4 antibodies in vitro requires allergen-specific and nonspecific activation of T and B cells. J. Allergy Clin. Immunol. 99:345-353.
6. 2 in vitro. J. Allergy Clin. Immunol. 93:758-767.
7. - memory T cells. J. Immunol. 159:4611-4619.
8. Fiorentino, D.F., A. Zlotnik, T.R. Mosmann, M. Howard, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822.
9. De Waal Malefyt, R., J. Abrams, B. Bennett, C.G. Figdor, and J.E. De Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209-1220.
10. Hsu, D.-H., K.W. Moore, and H. Spits. 1992. Differential effects of interleukin-4 and -10 on interleukin-2 induced interferon-γ synthesis and lymphokine activated killer activity. Int. Immunol. 4:563-569.
11. Del Prete, G., M. DeCarli, F. Almerigogna, M.G. Giudizi, R. Biagiotti, and S. Romagnani. 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150:353-360.
12. Schandene, L., C. Alonso-Vega, F. Willems, C. Gerard, A. Delvaux, T. Velu, R. Devos, M. de Boer, and M. Goldman. 1994. B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. J. Immunol. 152: 4368-4374.
13. Kagey-Sabotka, A., R.M. Franklin, N.F. Adkinson, Jr., M. Valentine, H. Bauer, and L.M. Lichtenstein. 1976. Allergy to insect sting. II. Phospholipase A: the major allergen in honey bee venom. J. Allergy Clin. Immunol. 57:29-40.
14. 2 from honey bee venom is similar. J. Allergy Clin. Immunol. 96:395-402.
15. 2. J. Immunol. 150:3582-3591.
16. Lucas, A.H. 1990. IgG subclass restricted immune responses to allergens. Semin. Immunopathol. 12:385-420.
17. Randolph, C.C., and R.E. Reismann. 1986. Evaluation of decline in serum venom specific IgE as a criterion for stopping venom immunotherapy. J. Allergy Clin. Immunol. 77:823-827.
18. Wyss, M., T. Scheitlin, B.M. Stadler, and B. Wüthrich. 1993. Immunotherapy with aluminum hydroxide adsorbed insect venom extracts (Alutard SQ): immunologic and clinical results of a prospective study over 3 years. Allergy. 48:81-86.
19. Reid, M.J., R.B. Moss, Y.P. Hsu, J.M. Kwasnicki, T.M. Commerford, and B.L. Nelson. 1986. Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy. J. Allergy Clin. Immunol. 78:590-600.
20. Hussain, R., R.W. Poindexter, and E.A. Ottesen. 1992. Control of allergic reactivity in human filariasis. Predominant localization of blocking antibodies to the IgG4 subclass. J. Immunol. 148:2731-2739.
21. Rocklin, R.E., A. Sheffer, D.K. Greineder, and K.L. Melmon. 1980. Generation of antigen-specific suppressor cells during allergy desensitization. N. Engl. J. Med. 302:1213-1219.
22. Otsuka, H., A. Mezawa, M. Ohnishi, K. Okubo, H. Seki, and M. Okuda. 1991. Changes in nasal metachromatic cells during allergen immunotherapy. Clin. Exp. Allergy. 21:115-120.
23. Crecitos, P.S., N. Franklin Adkinson, Jr., A. Kagey-Sobotka, D. Proud, H.L. Meier, R.M. Naclerio, L.M. Lichtenstein, and P.S. Norman. 1983. Nasal challenge with ragweed in hay fever patients. Effect of immunotherapy. J. Clin. Invest. 76:2247-2253.
24. Furin, M.J., P.S. Norman, P.S. Creticos, D. Proud, A. Kagey-Sobotka, L.M. Lichtenstein, and R.M. Naclerio. 1991. Immunotherapy decreases antigen-induced cosinophil migration into the nasal cavity. J. Allergy Clin. Immunol. 88:27-32.
25. Rak, S., O. Rowhagen, and P. Venge. 1988. The effect of immunotherapy on bronchial hyper-responsiveness and eosinophil cationic protein in pollen allergic patients. J. Allergy Clin. Immunol. 82:470-480.
26. Secrist, H., C.J. Chelen, Y. Wen, J.D. Marshall, and D.T. Umetsu. 1993. Allergen immunotherapy decreases interleukin 4 production in CD4 T cells from allergic individuals. J. Exp. Med. 178:2123-2130.
27. Jutel, M., W.J. Pichler, D. Skrbic, A. Urwyler, C. Dahinden, and U.R. Müller. 1995. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen stimulated T cell cultures. J. Immunol. 154:4187-4194.
28. + T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type. J. Exp. Med. 181:1081-1089.
29. Bellinghousen, I., G. Metz, A.H. Enk, S. Christmann, J. Knop, and J. Saloga. 1997. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects. Eur. J. Immunol. 27:1131-1139.
30. 2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J. Clin. Invest. 98: 1676-1683.
31. Mueller, H.L. 1966. Diagnosis and treatment of insect sensitivity. J. Asthma Res. 3:331-333.
32. Birnbaum, J., D. Charpin, and D. Vervloet. 1993. Rapid hymenoptera venom immuno-therapy: comparative safety of three protocols. Clin. Exp. Allergy. 23:226-230.
33. Von Grüningen, R., and C.H. Schneider. 1989. Antigenic structure of the hexacosa-peptide mellitin: evidence for three determinants, one with a helical conformation. Immunology. 66:339-342.
34. Lane, P., T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, and F.F. McConnell. 1993. Soluble CD40 ligand can replace the normal T cell derived CD40 ligand signal to B cells in T cell-dependent activation. J. Exp. Med. 177: 1209-1213.
35. + T cell clones and IL-4 induce IgG4 and IgE switching in purified B cells via different signaling pathways. J. Immunol. 147:8-13.
36. Prussin, C., and D. Metcalfe. 1995. Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J. Immunol. Methods. 188:117-125.
37. Miltenyi, S., W. Muller, W. Weichel, and A. Radbruch. 1990. A high gradient magnetic cell separation with MACS. Cytometry. 11:231-238.
38. 2. J. Allergy Clin. Immunol. 94:61-69.
39. Akdis, C.A., T. Blesken, M. Akdis, S.S. Alkan, C.H. Heusser, and K. Blaser. 1997. Glucocorticoids inhibit human antigen-specific and enhance total IgE and lgG4 production due to differential effects on T and B cells in vitro. Eur. J. Immunol. 27:2351-2357.
40. lck and Zap 70 tyrosine kinase activities. J. Immunol. 159:53-60.
41. Enk, A.H., J. Saloga, D. Becker, M. Mohamadzadeh, and J. Knop. 1994. Induction of hapten-specific tolerance by interleukin 10 in vivo. J. Exp. Med. 179:1397-1402.
42. Bacetta, R., M. Bigler, J.-L. Touraine, R. Parkman, P.-A. Tovo, J. Abrams, R. de Waal Malefyt, J.E. De Vries, and M.G. Roncarolo. 1994. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J. Exp. Med. 179:493-502.
43. Becker, J.C., C. Czerny, and E.-B. Bröcker. 1994. Maintenance of clonal anergy by endogenously produced IL-10. Int. Immunol. 6:1605-1612.
44. 2 induces specific T-cell anergy in patients allergic to bee venom. J. Allergy Clin. Immunol. In press.
45. Hoyne, G.F., R.E. O'Hehir, D.C. Wraith, W.R. Thomas, and J.R. Lamb. 1993. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitized mice. J. Exp. Med. 178:1783-1788.
46. Lichtenstein, L.M., M.D. Valentine, and A. Kagey-Sobotka. 1974. A case for venom treatment in anaphylactic sensitivity to hymenoptera sting. N. Engl. J. Med. 290:1223-1227.
47. + T-cell subset inhibits antigen-specific T cell responses and prevents colitis. Nature. 389:737-742.
48. Fiorentino, D.F., M.W. Bond, and T.R. Mosmann. 1989. Two types of mouse T helper cell IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081-2095.
49. Zuany-Amorim, C., S. Hailé, D. Leduc, C. Dumarey, M. Huerre, B.B. Vergaftig, and M. Pretolani. 1995. Interleukin 10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J. Clin. Invest. 95:2644-2651.
50. + T lymphocyte and eosinophil infiltration into the mouse peritoneal cavity. J. Immunol. 157:377-384.
51. Takanaski, S., R. Nonaka, Z. Xing, P. O'Byrne, J. Dolovich, and M. Jordana. 1994. Interleukin 10 inhibits lipopolysaccharide-induced survival and cytokine production by human peripheral blood eosinophils. J. Exp. Med. 180: 711-715.
52. Ohkawara, Y., K.G. Lim, M. Glibetic, K. Nakano, J. Dolovich, K. Croitoru, P.F. Weller, and M. Jordana. 1996. CD40 expression by human peripheral blood eosinophils. J. Clin Invest. 97:1761-1766.
53. Ding, L., and E.M. Shevach. 1992. IL-10 inhibits mitogen-induced T cell proliferation by selectively inhibiting macrophage co-stimulatory function. J. Immunol. 148:3133-3139.
54. Punnonen, J.R., R. de Waal Malefyt, P. van Vlasselaer, J.-F. Gauchat, and J.E. De Vries. 1993. IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J. Immunol. 151: 1280-1289.
55. Müller, U., and H. Mosbech. 1993. Position paper: immunotherapy with hymenoptera venoms. Allergy. 48(Suppl. 14):36-46.
56. Hunt, K., M. Valentine, A. Sobotka, A. Benton, F. Amoido, and L. Lichtenstein. 1978. A controlled trial of immunotherapy in insect hypersensitivity. N. Engl. J. Med. 299:157-161.
57. Arock, M., C. Zuany-Amorim, M. Singer, M. Benhamou, and M. Pretolani. 1996. Interleukin-10 inhibits cytokine generation from mast cells. Eur. J. Immunol. 26:166-170.
58. Marshall, J.S., I. Leal-Berumen, L. Nielsen, M. Glibetic, and M. Jordana. 1996. Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells. J. Clin. Invest. 97:1122-1128.
59. Jutel, M., U. Müller, M. Fricker, S. Rihs, W. Pichler, and C. Dahinden. 1996. Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils. Clin. Exp. Allergy. 26:1112-1118.
60. Schleimer, R.P., C.P. Derse, B. Friedmann, S. Gillis, M. Plaut, M.L. Lichtenstein, and D.W. Mac Glashan, Jr. 1989. Regulation of human basophil mediator release by cytokines. I. Interaction with anti-inflammatory steroids. J. Immunol. 143:1310-1317.
61. Brunner, T., C.H. Heusser, and C.A. Dahinden. 1993. Human peripheral blood basophils primed by interleukin 3 (IL-3) produce IL-4 in response to immunoglobulin E receptor stimulation. J. Exp. Med. 177:605-611.
62. Carballido, J.M., A. Faith, N. Carballido-Perrig, and K. Blaser. 1997. The intensity of T cell receptor engagement determines the cytokine pattern of human allergen-specific Th cells. Eur. J. Immunol. 27:515-521.